Instructions de recherche:
* Filter the ENTIRE resource library: Choose a OR a to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.
Parcourir les contenus (96 total)
-
Créateur: NETEC
Sujet: Infection Control
Type d'élément: Guide
Date de la dernière mise à jour: 2022-04-27
Description: This printable flyer infographic discusses the Role of the Trained Observer (TO) for Personal Protective Equipment (PPE). -
Créateur: Santarpia JL, Herrera VL, Rivera DN, Ratnesar-Shumate S, Reid SP, Ackerman DN, Denton PW, Martens JWS, Fang Y, Conoan N, Callahan MV, Lawler JV, Brett-Major DM, Lowe JJ.
Sujet: Infection Control
Type d'élément: Publication
Date de la dernière mise à jour: 2021-08-18
Description: Aerosol transmission of COVID-19 is the subject of ongoing policy debate. Characterizing aerosol produced by people with COVID-19 is critical to understanding the role of aerosols in transmission. -
Créateur: Smith, M. W., P. W. Smith, C. J. Kratochvil and S. Schwedhelm
Sujet: Personnel Management
Type d'élément: Publication
Date de la dernière mise à jour: 2017-02-01
Description: Caring for highly infectious patients in biocontainment units is a new phenomenon, and little is known about the behavioral health of workers in this setting.Example only: NETEC provides this item for reference purposes but does not endorse its content. Newer versions may be in place at the providing institution.
-
Créateur: NETEC
Sujet: Emergency Management
Type d'élément: Guide
Date de la dernière mise à jour: 2020-05-05
Description: The COVID-19 pandemic has forced healthcare providers to come up with creative, yet effective, ways to treat patients. Many of these innovations fall outside standard operating procedures - so it's important to make sure your emergency policies and… -
Créateur: NETEC
Sujet: Infection Control
Type d'élément: Guide
Date de la dernière mise à jour: 2019
Description: Attention all Staff - Stop - Poster -
Créateur: NETEC
Sujet: Intake and Internal Transport
Type d'élément: Protocole
Date de la dernière mise à jour: 2019-05-15
Description: Transfer Center and Admission Criteria - Transfer Center Ebola Virus Disease (EVD) Call Tree - Example -
Créateur: Cheung, Jonathan Chun-Hei, Lap Tin Ho, Justin Vincent Cheng, Esther Yin Kwan Cham, and Koon Ngai Lam.
Sujet: Personnel Management
Type d'élément: Publication
Date de la dernière mise à jour: 2020-02-24
Description: Medical professionals caring for patients with coronavirus disease 2019 (COVID-19) are at high risk of contracting the infection.Example only: NETEC provides this item for reference purposes but does not endorse its content. Newer versions may be in place at the providing institution.
-
Créateur: NETEC
Sujet: Infection Control
Type d'élément: Guide
Date de la dernière mise à jour: 2019-08-30
Description: Special Pathogens Precautions list - HCWs & Visitors: SEE NURSE BEFORE ENTERING -
Créateur: Kraft, Colleen S., Aneesh K. Mehta, Jay B. Varkey, G. Marshall Lyon, Sharon Vanairsdale, Sonia Bell, Eileen M. Burd, Mary Elizabeth Sexton, Leslie Anne Cassidy, Patricia Olinger, Kalpana Rengarajan, Vanessa N. Raabe, Emily Davis, Scott Henderson,…
Sujet: Personnel Management
Type d'élément: Publication
Date de la dernière mise à jour: 2020-04
Description: Healthcare personnel (HCP) were recruited to provide serum samples, which were tested for antibodies against Ebola or Lassa virus to evaluate for asymptomatic seroconversion.Example only: NETEC provides this item for reference purposes but does not endorse its content. Newer versions may be in place at the providing institution.
-
Créateur: Keehner, Jocelyn, Lucy E. Horton, Michael A. Pfeffer, Christopher A. Longhurst, Robert T. Schooley, Judith S. Currier, Shira R. Abeles, and Francesca J. Torriani.
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2021-03-23
Description: Data from phase 3 clinical trials of messenger RNA (mRNA) vaccines through November 2020 showed 94.1% efficacy for the prevention of symptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection at 14 days after the second dose…Example only: NETEC provides this item for reference purposes but does not endorse its content. Newer versions may be in place at the providing institution.